Zacks Investment ResearchThu, 09 Apr 2026 15:06:03 GMTIveda Reports Narrower Y/Y Loss in 2025 Despite Revenue DeclineIVDA+4.63%
Zacks Investment ResearchThu, 19 Feb 2026 15:07:24 GMTZacks Initiates Coverage of IVDA With Neutral RecommendationIVDA+4.63%